Thyroid cancer : from emergent biotechnologies to clinical practice guidelines /

"Thyroid cancer evaluation and treatment has enjoyed very little evolution in comparison with other disease management strategies. The standard treatment algorithms for thyroid cancer have varied only in response to major, though infrequent, biotechnological innovations. These resultant algorit...

Full description

Bibliographic Details
Main Authors: Carpi, A. (Angelo), Mechanick, Jeffrey I.
Format:
Language:eng
Published: Boca Raton, FL. : Taylor & Francis, c201
Subjects:
_version_ 1826451295557386240
author Carpi, A. (Angelo)
Mechanick, Jeffrey I.
author_facet Carpi, A. (Angelo)
Mechanick, Jeffrey I.
author_sort Carpi, A. (Angelo)
collection OCEAN
description "Thyroid cancer evaluation and treatment has enjoyed very little evolution in comparison with other disease management strategies. The standard treatment algorithms for thyroid cancer have varied only in response to major, though infrequent, biotechnological innovations. These resultant algorithm node insertions produced paradigm changes, but there has been little to advance the care of the patient with advanced thyroid cancer--until very recently. Perhaps the reasons for a relative lack of interest and scientific progress are the overwhelming likelihood of benignity among thyroid nodules, the overwhelmingly favorable clinical outcome even if a patient has thyroid cancer, and the overwhelming long time required for clinical follow-up of these cancer patients. Unfortunately, the problem now is that we may be overmanaging low-risk patients, and we have not achieved the clinical responses we would have liked with high-risk patients"--Provided by publisher.
first_indexed 2024-03-05T12:07:06Z
format
id KOHA-OAI-TEST:472416
institution Universiti Teknologi Malaysia - OCEAN
language eng
last_indexed 2024-03-05T12:07:06Z
publishDate c201
publisher Boca Raton, FL. : Taylor & Francis,
record_format dspace
spelling KOHA-OAI-TEST:4724162020-12-19T17:17:22ZThyroid cancer : from emergent biotechnologies to clinical practice guidelines / Carpi, A. (Angelo) Mechanick, Jeffrey I. Boca Raton, FL. : Taylor & Francis,c2011.eng"Thyroid cancer evaluation and treatment has enjoyed very little evolution in comparison with other disease management strategies. The standard treatment algorithms for thyroid cancer have varied only in response to major, though infrequent, biotechnological innovations. These resultant algorithm node insertions produced paradigm changes, but there has been little to advance the care of the patient with advanced thyroid cancer--until very recently. Perhaps the reasons for a relative lack of interest and scientific progress are the overwhelming likelihood of benignity among thyroid nodules, the overwhelmingly favorable clinical outcome even if a patient has thyroid cancer, and the overwhelming long time required for clinical follow-up of these cancer patients. Unfortunately, the problem now is that we may be overmanaging low-risk patients, and we have not achieved the clinical responses we would have liked with high-risk patients"--Provided by publisher.Includes bibliographical references and index."Thyroid cancer evaluation and treatment has enjoyed very little evolution in comparison with other disease management strategies. The standard treatment algorithms for thyroid cancer have varied only in response to major, though infrequent, biotechnological innovations. These resultant algorithm node insertions produced paradigm changes, but there has been little to advance the care of the patient with advanced thyroid cancer--until very recently. Perhaps the reasons for a relative lack of interest and scientific progress are the overwhelming likelihood of benignity among thyroid nodules, the overwhelmingly favorable clinical outcome even if a patient has thyroid cancer, and the overwhelming long time required for clinical follow-up of these cancer patients. Unfortunately, the problem now is that we may be overmanaging low-risk patients, and we have not achieved the clinical responses we would have liked with high-risk patients"--Provided by publisher.PSZJBLThyroid glandURN:ISBN:9781439862216 (hbk.)
spellingShingle Thyroid gland
Carpi, A. (Angelo)
Mechanick, Jeffrey I.
Thyroid cancer : from emergent biotechnologies to clinical practice guidelines /
title Thyroid cancer : from emergent biotechnologies to clinical practice guidelines /
title_full Thyroid cancer : from emergent biotechnologies to clinical practice guidelines /
title_fullStr Thyroid cancer : from emergent biotechnologies to clinical practice guidelines /
title_full_unstemmed Thyroid cancer : from emergent biotechnologies to clinical practice guidelines /
title_short Thyroid cancer : from emergent biotechnologies to clinical practice guidelines /
title_sort thyroid cancer from emergent biotechnologies to clinical practice guidelines
topic Thyroid gland
work_keys_str_mv AT carpiaangelo thyroidcancerfromemergentbiotechnologiestoclinicalpracticeguidelines
AT mechanickjeffreyi thyroidcancerfromemergentbiotechnologiestoclinicalpracticeguidelines